Tourette Disorder
13
2
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
15%
2 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (13)
Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder
Sensorimotor Integration in Patients With Tourette Syndrome
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics
Serotonin Control of Impulsivity in Tourette Disorder
Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder
Online-Delivered Comprehensive Behavioral Intervention for Tics-Enhanced (CBIT-E)
Guanfacine in Children With Tic Disorders
Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
Psychosocial Intervention for Young Children With Chronic Tics
Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
Subthalamic Stimulation in Tourette's Syndrome
Neuropsychological Functioning Among Children With Tourret's Disorder and ADHD